{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:03:42Z","timestamp":1791194622022,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mrfmmm.2004.04.021","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T08:15:47Z","timestamp":1103098547000},"page":"101-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":464,"title":["Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1"],"prefix":"10.1016","volume":"569","author":[{"given":"Frank J.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2004.04.021_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/mi.3.4.194","article-title":"Cytochromes p450, drugs, and diseases","volume":"3","author":"Guengerich","year":"2003","journal-title":"Mol. Intervent."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.abb.2003.11.019","article-title":"Functional characterization of four allelic variants of human cytochrome P4501A2","volume":"422","author":"Zhou","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00055735-200204000-00001","article-title":"Genetic basis of glaucoma","volume":"13","author":"WuDunn","year":"2002","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0026-895X(25)15384-4","article-title":"Purification and characterization of human liver microsomal cytochrome P-4502A6","volume":"40","author":"Yun","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1081\/DMR-100102338","article-title":"The human CYP3A subfamily: practical considerations","volume":"32","author":"Wrighton","year":"2000","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib7","first-page":"279","article-title":"Hepatocyte cultures in drug metabolism and toxicological research and testing","volume":"107","author":"Rogiers","year":"1998","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0027-5107(98)00037-2","article-title":"Activation of procarcinogens by human cytochrome P450 enzymes","volume":"400","author":"Guengerich","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.pa.35.040195.002101","article-title":"Cytochromes P450 expression systems","volume":"35","author":"Gonzalez","year":"1995","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/bbrc.1999.1913","article-title":"Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery","volume":"267","author":"Dalton","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-199608000-00002","article-title":"Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2","volume":"6","author":"Buters","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib12","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.96.5.1977","article-title":"Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas","volume":"96","author":"Buters","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib13","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1074\/jbc.271.20.12063","article-title":"Role of CYP2E1 in the hepatotoxicity of acetaminophen","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/taap.1998.8501","article-title":"Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice","volume":"152","author":"Zaher","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib15","doi-asserted-by":"crossref","first-page":"13607","DOI":"10.1016\/S0021-9258(17)38768-9","article-title":"Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes","volume":"260","author":"Koop","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00008571-200303000-00007","article-title":"Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6","volume":"13","author":"Yu","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0003-9861(02)00364-8","article-title":"Study of P450 function using gene knockout and transgenic mice","volume":"409","author":"Gonzalez","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib18","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib19","doi-asserted-by":"crossref","first-page":"23963","DOI":"10.1074\/jbc.274.34.23963","article-title":"Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene","volume":"274","author":"Miyata","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib20","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1074\/jbc.273.13.7382","article-title":"Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity","volume":"273","author":"Radjendirane","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib21","doi-asserted-by":"crossref","first-page":"46131","DOI":"10.1074\/jbc.M208675200","article-title":"Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity","volume":"277","author":"Long","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib22","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1073\/pnas.95.9.5275","article-title":"Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases","volume":"95","author":"Henderson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0300-483X(02)00288-3","article-title":"Transgenic models in xenobiotic metabolism and toxicology","volume":"181\/182","author":"Gonzalez","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.7732381","article-title":"Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor","volume":"268","author":"Fernandez-Salguero","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib25","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1073\/pnas.93.13.6731","article-title":"Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2443.1997.1490345.x","article-title":"Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor","volume":"2","author":"Mimura","year":"1997","journal-title":"Genes Cells"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib27","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/35038112","article-title":"The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism","volume":"407","author":"Wei","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/35019116","article-title":"Humanized xenobiotic response in mice expressing nuclear receptor SXR","volume":"406","author":"Xie","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib29","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib30","first-page":"1467","article-title":"Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor","volume":"29","author":"Staudinger","year":"2001","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib31","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1073\/pnas.051014398","article-title":"An essential role for nuclear receptors SXR\/PXR in detoxification of cholestatic bile acids","volume":"98","author":"Xie","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2275(20)30141-3","article-title":"Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor","volume":"43","author":"Kliewer","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib33","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR)","volume":"100","author":"Huang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib34","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1073\/pnas.0438010100","article-title":"Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor","volume":"100","author":"Xie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib35","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1073\/pnas.190256997","article-title":"Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice","volume":"97","author":"Lahvis","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib36","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1074\/jbc.M305832200","article-title":"Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice","volume":"279","author":"Andreola","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/tx00020a008","article-title":"Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects","volume":"4","author":"Guengerich","year":"1991","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1289\/ehp.021101213","article-title":"Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning","volume":"110","author":"Wan","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1089-3261(03)00025-4","article-title":"Acetaminophen hepatotoxicity","volume":"7","author":"Bromer","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)29664-1","article-title":"Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo","volume":"187","author":"Jollow","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3565(25)29663-X","article-title":"Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism","volume":"187","author":"Mitchell","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib42","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archinte.162.10.1193","article-title":"The effect of alcohol on acetaminophen hepatotoxicity","volume":"162","author":"Holtzman","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib43","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.1073\/pnas.220176997","article-title":"Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi","volume":"97","author":"Henderson","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1126\/science.1073502","article-title":"Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR","volume":"298","author":"Zhang","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib45","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0009-9120(99)00075-2","article-title":"Antioxidant enzymes and human diseases","volume":"32","author":"Mates","year":"1999","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1006\/abbi.2001.2630","article-title":"Reactive oxygen species and protein oxidation in aging: a look back, a look ahead","volume":"397","author":"Hensley","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib47","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1530-0277.2002.tb02621.x","article-title":"Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion","volume":"26","author":"Cahill","year":"2002","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib48","doi-asserted-by":"crossref","first-page":"15563","DOI":"10.1074\/jbc.M907022199","article-title":"CYP2E1 overexpression in HepG2 cells induces glutathione synthesis by transcriptional activation of gamma-glutamylcysteine synthetase","volume":"275","author":"Mari","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.pharmtox.44.101802.121704","article-title":"Oxidative stress, toxicology, and pharmacology of cyp2e1*","volume":"44","author":"Caro","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0006-2952(89)90338-9","article-title":"Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1)","volume":"38","author":"Ekstrom","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib51","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0016-5085(96)70028-8","article-title":"Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation","volume":"111","author":"Weltman","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib52","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib53","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1152\/ajpgi.2001.281.5.G1135","article-title":"Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress","volume":"281","author":"Robertson","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib54","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","article-title":"Model of nonalcoholic steatohepatitis","volume":"79","author":"Lieber","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib55","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1096\/fj.02-0078fje","article-title":"Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A","volume":"16","author":"Martinez-Chantar","year":"2002","journal-title":"Faseb. J."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib56","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/S0021-9258(18)94103-7","article-title":"Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization","volume":"264","author":"Song","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510270121","article-title":"Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis","volume":"27","author":"Weltman","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","article-title":"CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease","volume":"38","author":"Emery","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2003.50095","article-title":"Hepatic cytochrome P4502E1 activity in nondiabetic patients with nonalcoholic steatohepatitis","volume":"37","author":"Chalasani","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2125.2003.01731.x","article-title":"Diabetes mellitus increases the in vivo activity of cytochrome P4502E1 in humans","volume":"55","author":"Wang","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1472-8206.1998.tb00985.x","article-title":"Cytochrome P4502E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation","volume":"12","author":"Lucas","year":"1998","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"issue":"Pt. 3","key":"10.1016\/j.mrfmmm.2004.04.021_bib63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1042\/bj3320689","article-title":"Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia","volume":"332","author":"Bell","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib64","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/90.22.1702","article-title":"Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha","volume":"90","author":"Gonzalez","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib65","first-page":"863","article-title":"Effect of cytochrome P4502E1 inhibitors on cisplatin-induced cytotoxicity to renal proximal tubular epithelial cells","volume":"22","author":"Liu","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib66","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.1021\/bi00078a017","article-title":"Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates","volume":"32","author":"Dai","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib67","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/hep.20067","article-title":"CYP2E1 overexpression alters hepatocyte death from menadione and fatty acids by activation of ERK1\/2 signaling","volume":"39","author":"Schattenberg","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib68","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/biof.5520170128","article-title":"Redox signaling and the MAP kinase pathways","volume":"17","author":"Torres","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hepres.2003.08.001","article-title":"CYP2E1: from ASH to NASH","volume":"28","author":"Lieber","year":"2004","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib70","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/taap.1999.8756","article-title":"Metabolism of chloroform by cytochrome P4502E1 is required for induction of toxicity in the liver, kidney, and nose of male mice","volume":"160","author":"Constan","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2004.04.021_bib71","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/taap.1998.8547","article-title":"Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression","volume":"153","author":"Wong","year":"1998","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510704003756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510704003756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T14:05:58Z","timestamp":1764684358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510704003756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":71,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0027510704003756"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.04.021","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}